STOCK TITAN

Cyclacel Pharmaceuticals 6% Cnvrtbl. Prfrd. Stock (CYCCP) Revenue by Year

CYCCP

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock generated $747K in revenue in fiscal year 2025. This represents an increase of 1637.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock has filed alongside them.

FY2025 annual
Revenue $747K
YoY +1637.2%
5Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CYCCP Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$747K+1637.2%$43K-89.8%$420Kn/m$0n/m$0n/m$0N/A$150Kn/m$0-100.0%$843K-56.6%$1.9M+12.1%$1.7M+60.0%$1.1M+1471.0%$69K-90.1%$699K

CYCCP Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$743KN/A$81K+710.0%N/AN/A$0-100.0%$10K-37.5%$4K-98.9%$29Kn/m$31K$16Kn/m$373Kn/m

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock financials

Frequently Asked Questions

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock generated $747K in revenue in fiscal year 2025.

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) revenue rose by 1637.2% year over year, from $43K to $747K in fiscal year 2025.

Across the 15 fiscal years this page covers, Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) revenue went from $699K in fiscal year 2011 to $747K in fiscal year 2025.

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) reported $743K in revenue in Q1 2026.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) reported on that line in every period on record.